PARIS – French television personality Delphine Wespiser recently revealed that her partner, Roger Erhart, is battling cancer caused by the human papillomavirus (HPV). The announcement, made to Ici Paris, has sparked renewed discussion about the prevalence of HPV-related cancers and the importance of vaccination for both men and women. Wespiser described the diagnosis as a “stupid cancer that can be caught like a virus,” emphasizing the need for preventative measures.
The revelation comes after a year and a half of navigating the challenges of Erhart’s illness, a period Wespiser says they are determined to overcome. Her openness about their struggle aims to raise awareness about HPV and its potential to cause cancer, particularly in light of advancements in preventative healthcare.
Understanding HPV and HPV-Related Cancers
Human papillomavirus is a common viral infection, transmitted through skin-to-skin contact, most often during sexual activity. According to the Centers for Disease Control and Prevention (CDC), approximately 79 million Americans are currently infected with HPV . While many HPV infections clear up on their own, some can lead to the development of several types of cancer, including cervical, anal, oropharyngeal (back of the throat, including base of the tongue and tonsils), vaginal, vulvar and penile cancers.
The type of cancer Erhart is battling, oropharyngeal cancer linked to HPV, has been increasing in recent years, particularly among men. The National Cancer Institute (NCI) reports that HPV is responsible for approximately 70% of oropharyngeal cancers in the United States . This rise is attributed, in part, to changes in sexual behavior and increased oral sexual contact.
The Role of Vaccination in Preventing HPV-Related Cancers
Wespiser specifically highlighted the importance of HPV vaccination, noting that It’s recommended for girls as young as 11 to protect against cervical cancer. Though, she also stressed the crucial need for boys to be vaccinated, as HPV is often undetectable in males, leading to delayed diagnosis. The HPV vaccine works best when administered before exposure to the virus, which is why early vaccination is recommended.
The CDC recommends routine HPV vaccination for adolescents aged 11 or 12 years. Vaccination is also recommended for everyone through age 26 years, if not adequately vaccinated previously. Adults aged 27 through 45 years may also benefit from vaccination after discussing it with their healthcare provider . The vaccine protects against the types of HPV most commonly associated with cancer and genital warts.
Symptoms and Detection of HPV-Related Cancers
Early detection is critical in improving outcomes for HPV-related cancers. However, symptoms can be subtle or absent in the early stages. Symptoms of oropharyngeal cancer, for example, can include a persistent sore throat, difficulty swallowing, ear pain, and a lump in the neck. Regular screenings, such as Pap tests for cervical cancer, are essential for early detection.
The American Cancer Society emphasizes that We find no routine screening tests for HPV-related cancers of the anus, vagina, vulva, or penis . However, individuals should be aware of any unusual symptoms and consult a healthcare professional promptly.
Delphine Wespiser’s Advocacy and Raising Awareness
Wespiser’s decision to publicly discuss Erhart’s illness is a significant step in destigmatizing cancer and promoting preventative healthcare. Her platform as a well-known television personality provides an opportunity to reach a wide audience and encourage individuals to prioritize their health and consider HPV vaccination.
The actress and television host has been a prominent figure in French media, initially gaining recognition as Miss France in 2012. She has since hosted several popular television programs, including “L’Île de la Tentation” and “Qui veut épouser mon fils ?”. Her return to the latter show on M6 in 2026 has garnered significant media attention, but her recent focus has understandably shifted to supporting her partner and raising awareness about HPV.
Recent Developments in HPV Vaccination
In recent years, advancements in HPV vaccine technology have led to the development of a nine-valent vaccine that protects against nine HPV types, covering a broader range of cancer-causing strains. This vaccine has been shown to be highly effective in preventing HPV-related infections and cancers . The World Health Organization (WHO) is actively promoting global HPV vaccination programs to reduce the burden of HPV-related diseases.
research continues to explore the potential of therapeutic vaccines to treat existing HPV infections and cancers. While these vaccines are still in development, they offer hope for improved treatment options in the future.
Key Takeaways
- HPV is a common virus that can lead to several types of cancer.
- HPV vaccination is a safe and effective way to prevent HPV-related cancers.
- Vaccination is recommended for adolescents and young adults, but may also benefit older adults.
- Early detection of HPV-related cancers is crucial for improving outcomes.
- Raising awareness about HPV and promoting vaccination are essential public health priorities.
Delphine Wespiser’s courageous sharing of her partner’s health journey serves as a powerful reminder of the importance of preventative healthcare and the need for open conversations about cancer. As research continues to advance our understanding of HPV and its impact, continued efforts to promote vaccination and early detection will be vital in reducing the burden of these preventable diseases. The next step in raising awareness will be continued public health campaigns and increased access to vaccination resources.
If you have concerns about HPV or HPV-related cancers, please consult with your healthcare provider.